Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.

Kojima Y, Sasaki S, Kubota Y, Hayase M, Hayashi Y, Shinoura H, Tsujimoto G, Kohri K.

J Urol. 2008 Mar;179(3):1040-6. doi: 10.1016/j.juro.2007.10.082. Epub 2008 Jan 18.

PMID:
18206918
2.

Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.

Kojima Y, Sasaki S, Shinoura H, Hayase M, Kubota Y, Hayashi Y, Tsujimoto G, Kohri K.

Prostate. 2007 Sep 1;67(12):1285-92.

PMID:
17626248
3.

Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients.

Kojima Y, Sasaki S, Shinoura H, Hayashi Y, Tsujimoto G, Kohri K.

Prostate. 2006 May 15;66(7):761-7.

PMID:
16425183
4.

Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.

Hosoda C, Koshimizu TA, Tanoue A, Nasa Y, Oikawa R, Tomabechi T, Fukuda S, Shinoura H, Oshikawa S, Takeo S, Kitamura T, Cotecchia S, Tsujimoto G.

Mol Pharmacol. 2005 Mar;67(3):912-22. Epub 2004 Dec 14.

PMID:
15598970
5.

[A case of gastric endocrine cell carcinoma with neck lymph node metastasis resected after neoadjuvant chemotherapy].

Hasegawa K, Maruyama M, Takashima I, Maruyama S, Koide A, Obu M, Shinoura H, Kato K, Ebuchi M.

Gan To Kagaku Ryoho. 2004 Oct;31(11):1935-8. Japanese.

PMID:
15553765
6.

[Complication after self expandable metallic stent for esophageal cancer].

Nagahama T, Maruyama M, Kato K, Shinoura H, Hasegawa K, Takashima I, Ebuchi M.

Gan To Kagaku Ryoho. 2003 Oct;30(11):1750-3. Japanese.

PMID:
14619510
7.

[A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT].

Hasegawa K, Maruyama M, Nagahama T, Takashima I, Shinoura H, Kato K, Ebuchi M.

Gan To Kagaku Ryoho. 2003 Oct;30(11):1678-81. Japanese.

PMID:
14619492
8.

Responses to noxious stimuli in mice lacking alpha(1d)-adrenergic receptors.

Harasawa I, Honda K, Tanoue A, Shinoura H, Ishida Y, Okamura H, Murao N, Tsujimoto G, Higa K, Kamiya HO, Takano Y.

Neuroreport. 2003 Oct 6;14(14):1857-60.

PMID:
14534435
9.

Key amino acids for differential coupling of alpha1-adrenergic receptor subtypes to Gs.

Shinoura H, Shibata K, Hirasawa A, Tanoue A, Hashimoto K, Tsujimoto G.

Biochem Biophys Res Commun. 2002 Nov 22;299(1):142-7.

PMID:
12435400
10.

alpha 1-Adrenergic receptor subtypes differentially control the cell cycle of transfected CHO cells through a cAMP-dependent mechanism involving p27Kip1.

Shibata K, Katsuma S, Koshimizu T, Shinoura H, Hirasawa A, Tanoue A, Tsujimoto G.

J Biol Chem. 2003 Jan 3;278(1):672-8. Epub 2002 Oct 29.

11.

Antagonistic effects of antimuscarinic drugs on alpha 1-adrenoceptors.

Shinoura H, Tsujimoto G, Teranishi Y, Tsuru H.

Naunyn Schmiedebergs Arch Pharmacol. 2002 Oct;366(4):368-71. Epub 2002 Jul 16.

PMID:
12237751
12.

The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.

Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, Sunada S, Takeo S, Tsujimoto G.

J Clin Invest. 2002 Mar;109(6):765-75.

13.

Galphaq-dependent activation of mitogen-activated protein kinase kinase 4/c-Jun N-terminal kinase cascade.

Yamauchi J, Itoh H, Shinoura H, Miyamoto Y, Tsumaya K, Hirasawa A, Kaziro Y, Tsujimoto G.

Biochem Biophys Res Commun. 2001 Nov 16;288(5):1087-94.

PMID:
11700022
14.

Regulation of subcellular localization of alpha1-adrenoceptor subtypes.

Hirasawa A, Awaji T, Xu Z, Shinoura H, Tsujimoto G.

Life Sci. 2001 Apr 6;68(19-20):2259-67.

PMID:
11358335
15.

Involvement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase in alpha1B-adrenergic receptor/Galphaq-induced inhibition of cell proliferation.

Yamauchi J, Itoh H, Shinoura H, Miyamoto Y, Hirasawa A, Kaziro Y, Tsujimoto G.

Biochem Biophys Res Commun. 2001 Mar 9;281(4):1019-23.

PMID:
11237765
16.

Key amino acids of vasopressin V1a receptor responsible for the species difference in the affinity of OPC-21268.

Shinoura H, Take H, Itoh S, Hirasawa A, Inoue K, Ohno Y, Hashimoto K, Tsujimoto G.

FEBS Lett. 2000 Jan 28;466(2-3):255-8. Erratum in: FEBS Lett 2000 Jun 2;474(2-3):257.

17.

Interaction of the alpha(1B)-adrenergic receptor with gC1q-R, a multifunctional protein.

Xu Z, Hirasawa A, Shinoura H, Tsujimoto G.

J Biol Chem. 1999 Jul 23;274(30):21149-54.

18.
19.

Real-time optical monitoring of ligand-mediated internalization of alpha1b-adrenoceptor with green fluorescent protein.

Awaji T, Hirasawa A, Kataoka M, Shinoura H, Nakayama Y, Sugawara T, Izumi S, Tsujimoto G.

Mol Endocrinol. 1998 Aug;12(8):1099-111.

PMID:
9717836
20.

Progressive multifocal leukoencephalopathy resembling central nervous system systemic lupus erythematosus.

Kinoshita M, Iwana K, Shinoura H, Aotsuka S, Sumiya M.

Clin Exp Rheumatol. 1998 May-Jun;16(3):313-5.

PMID:
9631757
21.

Diffuse interstitial pulmonary amyloidosis in rheumatoid arthritis.

Sumiya M, Ohya N, Shinoura H, Kinoshita M, Aotsuka S, Ishida T, Morita T.

J Rheumatol. 1996 May;23(5):933-6.

PMID:
8724311
22.

Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus.

Hashimoto H, Tsuda H, Kanai Y, Kobayashi S, Hirose S, Shinoura H, Yokohari R, Kinoshita M, Aotsuka S, Yamada H, et al.

J Rheumatol. 1991 Apr;18(4):545-51.

PMID:
2066947

Supplemental Content

Loading ...
Support Center